Evidence map›Paper›PMID 41670122›Full record

ArticleGenome biology and evolution2026

Transcriptomic Adjustment to Decreasing Oxygen Reveals Novel Functional Strategies for Extreme Hypoxia Tolerance in the Copepod Tigriopus californicus.

Matthew J Powers, Felipe S Barreto

Abstract read
In one paragraph

Article in Genome biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew J PowersDepartment of Integrative Biology, Oregon State University, Corvallis, OR, USA.ORCID 0000-0003-3499-0877
Felipe S BarretoDepartment of Integrative Biology, Oregon State University, Corvallis, OR, USA.ORCID 0000-0002-7949-7747

Funding

National Science Foundation 2037574
6 · The paper itself

Abstract

Hypoxia-induced regulatory changes are well understood across aquatic and terrestrial systems. These changes are normally initiated by elements belonging to hypoxia-inducible factor (HIF) pathway. These elements generate responses that help organisms survive hypoxia, such as protein stabilization, antioxidant activity, or the switch from aerobic to anaerobic metabolism. The HIF pathway is initiated by the transcription factor HIF-α via deactivation of its repressor EGLN. However, recent work revealed that many aquatic invertebrates do not possess HIF-α or EGLN. Among these is the intertidal copepod Tigriopus californicus. Although this copepod experiences daily bouts of hypoxia, T. californicus tolerates even extended anoxia with minimal mortality. Because T. californicus lacks HIF-α, it is unclear how the transcriptional response proceeds on a fine timescale in this species and which physiological strategies they use to cope with severe hypoxia. In this study, we captured gene expression over a species-typical course of hypoxia including normoxia, mild hypoxia (∼3.5 mg O2 L-1), at critical oxygen tension (Pcrit; ∼0.5 mg O2 L-1), anoxia (0 mg O2 L-1), and recovery. We identified and clustered genes affected by this hypoxia course and tested for enrichment of Gene Ontology and transcription factor binding site motifs. We identified genes with known responses to hypoxia, including genes with interactions with HIF-α in other systems. We also identified genes related to functions unique to T. californicus, including exoskeletal modifications that could represent a specialized response allowing T. californicus to persist in extreme hypoxic environments despite lacking HIF-α.

Indexed as

Adaptation, PhysiologicalCopepodaHypoxiaOxygenTranscriptomeAnimalsHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor 1, alpha SubunitOxygenanoxiacarotenoidsexoskeletonglycolysisP crittrehalose

Identifiers

PMID41670122
PMCPMC12962235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.